Transcriptional analysis of targets in multiple sclerosis
- 1 June 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 3 (6) , 483-492
- https://doi.org/10.1038/nri1108
Abstract
Large-scale analyses of messenger RNA transcripts and autoantibody responses, taken from the actual sites of disease, provide us with an unprecedented view of the complexity of autoimmunity. Despite an appreciation of the large number of pathways and pathological processes that are involved in these diseases, a few practical targets and several new strategies have emerged from these studies. This review focuses on multiple sclerosis and on the approaches that are being used to identify new targets that might be manipulated to control this disease.Keywords
This publication has 55 references indexed in Scilit:
- Response to Comment on "The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease"Science, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight LossScience, 2002
- Proteomics for the Development of DNA Tolerizing Vaccines to Treat Autoimmune DiseaseClinical Immunology, 2002
- Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for TherapyAnnual Review of Neuroscience, 2002
- Combination of Gene Delivery and DNA Vaccination to Protect from and Reverse Th1 Autoimmune Disease via Deviation to the Th2 PathwayImmunity, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Autoimmune DiseaseScientific American, 1993
- Die Schutzstoffe des BlutesDeutsche Medizinische Wochenschrift (1946), 1901